Copyright
©The Author(s) 2024.
World J Hepatol. Feb 27, 2024; 16(2): 177-185
Published online Feb 27, 2024. doi: 10.4254/wjh.v16.i2.177
Published online Feb 27, 2024. doi: 10.4254/wjh.v16.i2.177
Sample | Cases | LCN2 level | Ref. |
Blood | 675 mild chronic hepatitis B, 178 moderate chronic hepatitis B, 199 severe chronic hepatitis B and 317 fulminant hepatitis B, 246 healthy volunteers | Chronic hepatitis, fulminant hepatitis significantly higher than control | [37] |
Blood | 54 patients with HBV-ACLF and 49 patients with CHB | HBV-ACLF higher than CHB | [38] |
Blood and urine | 64 patients with cirrhosis and 23 control subjects | Cirrhosis with hepatorenal syndrome patients is significantly higher than controls, no difference between stable cirrhosis and control | [39] |
Blood | 192 patients with chronic liver diseases of variable etiology and clinical severity in comparison to 91 healthy controls | Chronic liver diseases were higher than healthy controls No significant differences between cirrhotic and non-cirrhotic patients | [40] |
Blood | 48 patients with chronic HCV | Not correlated with HCV viral load | [41] |
Blood | 87 Egyptian patients with chronic hepatitis C infection | Significantly decrease after HCV treatment with DAA | [42] |
Blood | 102 chronic hepatitis C virus infection | Significantly increase after HCV treatment with DAA | [43] |
- Citation: Chen F, Wu SS, Chen C, Zhou C. Dynamic changes and clinical value of lipocalin 2 in liver diseases caused by microbial infections. World J Hepatol 2024; 16(2): 177-185
- URL: https://www.wjgnet.com/1948-5182/full/v16/i2/177.htm
- DOI: https://dx.doi.org/10.4254/wjh.v16.i2.177